Axel Fun

865 total citations
15 papers, 391 citations indexed

About

Axel Fun is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Axel Fun has authored 15 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 12 papers in Virology and 3 papers in Molecular Biology. Recurrent topics in Axel Fun's work include HIV/AIDS drug development and treatment (13 papers), HIV Research and Treatment (12 papers) and HIV/AIDS Research and Interventions (8 papers). Axel Fun is often cited by papers focused on HIV/AIDS drug development and treatment (13 papers), HIV Research and Treatment (12 papers) and HIV/AIDS Research and Interventions (8 papers). Axel Fun collaborates with scholars based in Netherlands, United States and Germany. Axel Fun's co-authors include Monique Nijhuis, Annemarie M. J. Wensing, Jens Verheyen, Linos Vandekerckhove, Nele Brusselaers, Peter Messiaen, Mark R. Wills, Hoi Ping Mok, Andrew Lever and P Schipper and has published in prestigious journals such as PLoS ONE, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Axel Fun

15 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Axel Fun Netherlands	11	302	287	65	64	56	15	391
Gabrielle Heilek‐Snyder United States	6	304 1.0×	316 1.1×	53 0.8×	32 0.5×	44 0.8×	7	351
Alex Dusek United States	5	324 1.1×	302 1.1×	58 0.9×	28 0.4×	66 1.2×	7	399
Sophie Sayon France	15	435 1.4×	397 1.4×	107 1.6×	38 0.6×	106 1.9×	41	577
Jean Pierre Routy Canada	6	186 0.6×	211 0.7×	33 0.5×	38 0.6×	66 1.2×	9	268
Eduardo Seclén Spain	11	247 0.8×	265 0.9×	59 0.9×	72 1.1×	102 1.8×	18	375
Erin Stuelke United States	5	163 0.5×	220 0.8×	57 0.9×	53 0.8×	34 0.6×	7	257
Shabir Lakhi United States	10	179 0.6×	321 1.1×	44 0.7×	181 2.8×	58 1.0×	16	365
Rúbia Marília de Medeiros Brazil	15	236 0.8×	309 1.1×	49 0.8×	79 1.2×	151 2.7×	25	448
Rachanee Cheingsong United States	9	306 1.0×	332 1.2×	27 0.4×	62 1.0×	61 1.1×	9	380
Jason Isaacson United States	6	269 0.9×	317 1.1×	108 1.7×	40 0.6×	58 1.0×	6	376

Countries citing papers authored by Axel Fun

Since Specialization

Citations

This map shows the geographic impact of Axel Fun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Fun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Fun more than expected).

Fields of papers citing papers by Axel Fun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Fun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Fun. The network helps show where Axel Fun may publish in the future.

Co-authorship network of co-authors of Axel Fun

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Fun. A scholar is included among the top collaborators of Axel Fun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Fun. Axel Fun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Fun, Axel, Thomas Leitner, Linos Vandekerckhove, et al.. (2018). Impact of the HIV-1 genetic background and HIV-1 population size on the evolution of raltegravir resistance. Retrovirology. 15(1). 1–1. 10 indexed citations

Mok, Hoi Ping, et al.. (2018). No evidence of ongoing evolution in replication competent latent HIV-1 in a patient followed up for two years. Scientific Reports. 8(1). 11 indexed citations

Fun, Axel, et al.. (2017). Innovations in the quantitative virus outgrowth assay and its use in clinical trials. Retrovirology. 14(1). 58–58. 6 indexed citations

Fun, Axel, Hoi Ping Mok, Mark R. Wills, & Andrew Lever. (2017). A highly reproducible quantitative viral outgrowth assay for the measurement of the replication-competent latent HIV-1 reservoir. Scientific Reports. 7(1). 43231–43231. 28 indexed citations

Hofstra, L. Marije, Monique Nijhuis, Tania Mudrikova, et al.. (2014). Use of dolutegravir in two INI‐experienced patients with multiclass resistance resulted in excellent virological and immunological responses. Journal of the International AIDS Society. 17(4S3). 19755–19755. 3 indexed citations

Messiaen, Peter, Annemarie M. J. Wensing, Axel Fun, et al.. (2013). Clinical Use of HIV Integrase Inhibitors: A Systematic Review and Meta-Analysis. PLoS ONE. 8(1). e52562–e52562. 82 indexed citations

Fun, Axel, Annemarie M. J. Wensing, Jens Verheyen, & Monique Nijhuis. (2012). Human Immunodeficiency Virus gag and protease: partners in resistance. Retrovirology. 9(1). 63–63. 106 indexed citations

Maarseveen, Noortje M. van, Dan I. Andersson, Martin Lepšı́k, et al.. (2012). Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity. Retrovirology. 9(1). 29–29. 11 indexed citations

Fun, Axel, Noortje M. van Maarseveen, Jana Pokorná, et al.. (2011). HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat. Retrovirology. 8(1). 70–70. 21 indexed citations

10.

Fun, Axel, Karen Van Baelen, S.F.L. van Lelyveld, et al.. (2010). Mutation Q95K enhances N155H-mediated integrase inhibitor resistance and improves viral replication capacity. Journal of Antimicrobial Chemotherapy. 65(11). 2300–2304. 13 indexed citations

11.

Verheyen, Jens, Chris Verhofstede, Elena Knops, et al.. (2010). High prevalence of bevirimat resistance mutations in protease inhibitor-resistant HIV isolates. AIDS. 24(5). 669–673. 25 indexed citations

12.

Verheyen, Jens, Chris Verhofstede, Elena Knops, et al.. (2009). High prevalence of bevirimat resistance mutations in non-B subtypes and in PI-resistant HIV isolates. Antiviral Therapy. 14(4). 127. 1 indexed citations

13.

Reinink, Peter, Roel Hermsen, Dirk M. Zajonc, et al.. (2009). Functional CD1d and/or NKT cell invariant chain transcript in horse, pig, African elephant and guinea pig, but not in ruminants. Molecular Immunology. 46(7). 1424–1431. 41 indexed citations

14.

Nijhuis, Monique, Annemarie M. J. Wensing, Wouter F.W. Bierman, et al.. (2009). Failure of Treatment with First‐Line Lopinavir Boosted with Ritonavir Can Be Explained by Novel Resistance Pathways with Protease Mutation 76V. The Journal of Infectious Diseases. 200(5). 698–709. 28 indexed citations

15.

Fun, Axel, et al.. (1985). Defective Leukocyte Interferon Response in Children with Recurrent Infections Accompanied by Arthralgia. Acta Paediatrica. 74(2). 219–225. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact